Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Synthetic Hybrid Receptors for Safer and Programmable T Cell Therapy.
Journal: bioRxiv : the preprint server for biology
Published: February 06, 2026
IFN signaling is associated with radiotherapy response in malignant peripheral nerve sheath tumors.
Journal: The Journal of clinical investigation
Published: May 14, 2025
Management of Concurrent Malignant Phyllodes Tumor and Invasive Breast Carcinoma.
Journal: Advances in radiation oncology
Published: September 26, 2023
Engineered receptors for soluble cellular communication and disease sensing.
Journal: Nature
Published: June 20, 2023
Synthesizing a Smarter CAR T Cell: Advanced Engineering of T-cell Immunotherapies.
Journal: Cancer immunology research
Published: December 11, 2022
Naturally occurring T cell mutations enhance engineered T cell therapies.
Journal: Nature
Published: September 20, 2022
Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 23, 2022
Synthetic biology: at the crossroads of genetic engineering and human therapeutics-a Keystone Symposia report.
Journal: Annals of the New York Academy of Sciences
Published: October 05, 2021
Modular design of synthetic receptors for programmed gene regulation in cell therapies.
Journal: Cell
Published: May 11, 2021
Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor.
Journal: Nature communications
Published: July 02, 2018
Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 08, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026